Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2973522 | The Journal of Heart and Lung Transplantation | 2005 | 5 Pages |
Abstract
The incidence of PSP in LL recipients is similar to that reported in the literature on cadaveric transplant recipients. The relatively small lobe in the potentially contaminated chest cavity of cystic fibrosis recipients does not significantly pre-dispose to development of empyema despite immunosuppression. Many PSP can be managed non-operatively, although early aggressive intervention for large air leaks and judicious chest tube management are essential for a good outcome.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Leah M. MD, Eric M. MD, Felicia A. RN, BS, Mark L. MD, Robbin G. MD, Michael A. MD, Vaughn A. MD, Ross M. MD, PhD,